Provectus Biopharmaceuticals, Inc. (PVCT): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2017-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$10.38M
Year ended 2017-12-31
2009-12-31: -$8.60M2011-12-31: -$17.21M2012-12-31: -$11.27M2013-12-31: -$9.90M2014-12-31: -$13.92M2015-12-31: -$17.42M2017-12-31: -$10.38M-$10.38M
2009-12-31 Free Cash Flow (USD) 2017-12-31
Period endedFree Cash FlowChange YoYSource filing
2017-12-31-$10.38Mn/a2019-03-07, From 2017-01-01
No annual figure between 2015-12-31 and 2017-12-31.
2015-12-31-$17.42Mn/m2017-03-31, From 2015-01-01
2014-12-31-$13.92Mn/m2017-03-31, From 2014-01-01
2013-12-31-$9.90Mn/m2016-03-30, From 2013-01-01
2012-12-31-$11.27Mn/m2015-03-12, From 2012-01-01
2011-12-31-$17.21Mn/a2014-03-13, From 2011-01-01
No annual figure between 2009-12-31 and 2011-12-31.
2009-12-31-$8.60Mn/a2012-03-14, From 2009-01-01